MedPath

Efficacy and safety of regular treatment with procaterol and budesonide inhalation suspension for young children with moderate persistent asthma.

Phase 4
Conditions
Bronchial Asthma
Registration Number
JPRN-UMIN000003492
Lead Sponsor
niversity of Toyama, Faculty of Medicine, Department of Pediatrics
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1.Patients who have an event listed below within a month a)Respiratory infection disease that required hospitalization b)Administration of systemic corticosteroids 2.Recieving regular use of inhaled corticosteroids or beta 2 agonists in the previous 3 months 3.Patients who have severe chronic diseases 4.Patients who have chronic low airway diseases other than bronchial asthma 5.Any other children considered by the attending physicians as inappropriate for participation in this study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath